Drug Repurposing to Circumvent Immune Checkpoint Inhibitor Resistance in Cancer Immunotherapy

Immune checkpoint inhibitors (ICI) have achieved unprecedented clinical success in cancer treatment. However, drug resistance to ICI therapy is a major hurdle that prevents cancer patients from responding to the treatment or having durable disease control. Drug repurposing refers to the application...

Descripción completa

Detalles Bibliográficos
Autores principales: To, Kenneth K. W., Cho, William C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459070/
https://www.ncbi.nlm.nih.gov/pubmed/37631380
http://dx.doi.org/10.3390/pharmaceutics15082166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459070/
https://www.ncbi.nlm.nih.gov/pubmed/37631380
http://dx.doi.org/10.3390/pharmaceutics15082166

Ejemplares similares